GlaxoSmithKline’s $1.9 Billion Acquisition of Sierra Oncology

Cleary Gottlieb Steen & Hamilton advised GlaxoSmithKline, while Wilson Sonsini Goodrich & Rosati advised Sierra Oncology on the deal.GlaxoSmithKline plc (LSE/NYSE: GSK) has entered into an agreement…

This content is for Standard 1 Year members only.
Login Join Now

Modal’s $25 Million Series A Financing Round

AGL Credit Management’s Private Credit Partnership With Barclays

Enbridge’s Joint Venture with WhiteWater, I Squared and MPLX

Eurofarma Laboratorios’ R$3 Billion Debentures Issuance

Inmuebles Panamericana’s S/110 Million Securitized Bonds Issuance

Drip-Plan’s Acquisition of Nordeste Irrigação

SGS SA’s Scrip Dividend Transaction

Centralis Group’s Acquisition of YLP

EnBW’s Partnership With Narrowin GmbH

KOKO Networks Limited’s Financing Round

India Vehicle Finance’s Notes Offering

Al-Arafa’s Demerger into Concrete Fashion Group and GTEX

Franklin Templeton’s Launch in Saudi Arabia

Savino Del Bene’s Acquisition of Stakes in Trans Okyanus and Bogazici Ekspres

National Finance Co. S.A.O.G.’s OMR25 Million Unsecured Bonds Issuance

JSW Energy’s Qualified Institutions Placement

Bloomberg’s Victory in the Supreme Court of India

Singapore Airlines’ Bonds Offering

McDermott Supercharges International Tax Capabilities with Addition of Two Partners in Paris

Venable LLP adds three Product Liability/Mass Torts partners in Chicago and LA

Curtis Announces New Partners and Counsels Across Offices in Spring 2024

The Distinctive Character Of The ‘Vespa’ Is No Longer In Question

Cultural Heritage Sites With Restrictions On Intended Use: The Council of State Acknowledges That This Power Lies In the Hands Of The Ministry Of Culture

The Italian Revenue Agency Qualifies Directors’ Reversible Remuneration For The Purposes Of Double Taxation Agrements.

McDermott Supercharges International Tax Capabilities with Addition of Two Partners in Paris

BMH BRÄUTIGAM becomes NEON

Venable LLP adds three Product Liability/Mass Torts partners in Chicago and LA

GlaxoSmithKline’s $1.9 Billion Acquisition of Sierra Oncology

Author: Laura Testa